Chilean Healthcare NGOs Release Adaptation of Exhaustive Canadian Obesity Guidelines
Chile launches evidence-based approach to obesity care rooted in Canada’s watershed 2020 clinical practice guidelinesEDMONTON, Alberta, Nov. 14, 2022 (GLOBE...
Nutrition
Walmart Canada and TELUS Health join forces to provide Walmart associates with comprehensive virtual health and wellbeing services
Over 100,000 associates will benefit from the full suite of TELUS Health’s digital employer health solutions, as retailer becomes first...
Ravkoo Health Joins Leading Healthcare Companies at HLTH 2022
HLTH Banner Ravkoo Health Joins Leading Healthcare Companies at HLTH 2022LAS VEGAS, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Ravkoo Health,...
Ceapro Inc. Launches Next Phase of Scale Up for its Disruptive PGX Technology to Pursue Product Development for Nutraceutical and Pharmaceutical Markets
PGX processing unit to be installed at Agri-Food Discovery Place of University of AlbertaAlginate and yeast beta glucan to be...
Healthy Extracts Introduces New Video Series Hosted by Fitness & Nutrition Expert, Whitney Johns, and America’s Healthy Heart Doc, Joel Kahn
First Episode Discusses Natural Ways to Improve Cardiovascular & Sexual Health with the ‘Miracle Molecule,’ Nitric Oxide YouTube Video Series...
Albireo Announces 2022 SPARK Grant Winners
— Eight projects selected for inaugural year of the program — Projects provide solutions to make a tangible difference in...
QHSLab, Inc. Meets the Demand for Updated Mental Health Screening Recommendations from the U.S. Preventive Services Task Force
The latest recommendations from the U.S. Preventive Services Task Force (USPSTF) indicate that all adults under the age of 65...
Better Choice Company to Host Third Quarter 2022 Earnings Call on November 10th at 8:30 a.m. ET
NEW YORK, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet...
Dyadic to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022
JUPITER, Fla., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI),...
Aphaia Pharma Announces Enrollment of First Patient in Phase 2 Study of APH-012 for Chronic Weight Management in Individuals with Obesity
ZUG, Switzerland, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Aphaia Pharma, a clinical-stage biopharmaceutical company harnessing precision-targeted drug delivery technology for...
Obesity Canada Publishes First Update to 2020 Adult Clinical Practice Guidelines
Emerging research captured in revised chapters summarizing evidence for medical nutrition therapy and pharmacotherapyEDMONTON, Alberta, Oct. 21, 2022 (GLOBE NEWSWIRE)...
Data from Roll-In Cohort of North American pivotal alfapump® study (POSEIDON) selected for poster presentation at AASLD The Liver Meeting®
Presentation by Dr. Florence Wong on Sunday November 6thin Washington, DC:“An Automatic Low Flow Ascites Pump Improves Ascites Control and...
Simply Better Brands Corp, Growing 359% vs Year Ago Preliminarily Sales Results Year to Date, Announces Its Trubar Brand’s Accelerated Expansion of Its Portfolio and Distribution
Women-founded, Women-led Nutrition Brand Expands Dessert-inspired, Plant-Based brand in flavor innovation, category expansion and retail footprint TRUBAR 2021 vs 2022...
Base Healthcare Launches Innovative Platform for Men with Testosterone Deficiency
RALEIGH, N.C., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Base Healthcare today announced the official launch of its subscription-based men’s virtual...
Ceapro Inc. Announces Positive Data from Bioavailability Studies Evaluating CoQ10 Formulations Impregnated with PGX-Processed Carriers
Findings from this collaborative project with the University of Alberta using a unique surgical methodology illustrate how PGX-processed carriers can...
Albireo Presents Data on Greater Efficacy in PFIC with Earlier Bylvay® Treatment at NASPGHAN
– New data presented at the North American Society for Pediatric Gastroenterology, Hepatology & Nutrition meeting (NASPGHAN) – Earlier treatment...
BioCorRx Completes Final Subject Enrollment in Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
ANAHEIM, CA, Oct. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and...
VectivBio Reports Positive Interim Clinical Data from STARS Nutrition, a Phase 2 Study Investigating Apraglutide in Short Bowel Syndrome with Intestinal Failure Patients (SBS-IF) with Colon-In-Continuity (CIC)
• Treatment with apraglutide resulted in an average 50% reduction in Parenteral Support (PS) volume at six months • 80% of...
Rhythm Pharmaceuticals Convenes Inaugural International Meeting on Pathway-Related Obesity: Vision of Excellence (IMPROVE) 2022
-- Approximately 100 European health care professionals invited to discuss recent scientific developments in rare pathway-related obesities -- -- Rhythm...
Procaps Announces ESG Commitments and Initiatives with Inaugural Report
MIAMI and BARRANQUILLA, Colombia, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare...